Cargando…
Preclinical Pharmacokinetics of C118P, a Novel Prodrug of Microtubules Inhibitor and Its Metabolite C118 in Mice, Rats, and Dogs
C118P, a phosphate prodrug of C118, which is a novel microtubule protein inhibitor, is currently under Phase I clinical development in China for treating ovarian cancer and lung cancer. The preclinical pharmacokinetics of prodrug C118P and its metabolite C118 were extensively characterized in vivo i...
Autores principales: | Zhang, Cang, Zhang, Xiaolan, Wang, Guangji, Peng, Ying, Zhang, Xueyuan, Wu, Hui, Yu, Boyang, Sun, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278385/ https://www.ncbi.nlm.nih.gov/pubmed/30400617 http://dx.doi.org/10.3390/molecules23112883 |
Ejemplares similares
-
Klaviertücke Op. 118
por: Brahms, Johannes, 1833-1897
Publicado: (1976) -
118th SPSC Meeting
Publicado: (2015) -
118th LHCC Meeting
Publicado: (2014) -
Study of the polarization of antiproton in scattering at 1.18 GeV/c
por: Dobrzynski, L, et al.
Publicado: (1966) -
Decreased tumorigenesis in mice with a Kras point mutation at C118
por: Huang, Lu, et al.
Publicado: (2014)